Concepedia

Publication | Open Access

In Type 2 Diabetes, Rosiglitazone Therapy for Insulin Resistance Ameliorates Endothelial Dysfunction Independent of Glucose Control

DOIFull Paper Access

230

Citations

26

References

2004

Year

Frank Pistrosch, Jens Passauer, Sabine Fischer, Katja Fuecker, M Hanefeld
Diabetes Care

Abstract

Insulin resistance is a major contributor toward endothelial dysfunction in type 2 diabetes. Both endothelial dysfunction and insulin resistance are amenable to treatment by rosiglitazone.

References

YearCitations

Page 1